Orion Portfolio Solutions’s Sarepta Therapeutics SRPT Stock Holding History

Orion Portfolio Solutions’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$663K	Buy	10,385 +2,358	+29%	+$248K	0.01%	1277
2024 Q4	$976K	Sell	8,027 -1,731	-18%	-$212K	0.01%	1070
2024 Q3	$1.22M	Sell	9,758 -177	-2%	-$24.5K	0.01%	944
2024 Q2	$1.57M	Sell	9,935 -161	-2%	-$20.7K	0.02%	765
2024 Q1	$1.31M	Buy	10,096 +3,123	+45%	+$383K	0.01%	866
2023 Q4	$716K	Sell	6,973 -7,183	-51%	-$689K	0.01%	1077
2023 Q3	$1.72M	Buy	14,156 +1,198	+9%	+$135K	0.02%	683
2023 Q2	$1.48M	Buy	12,958 +8,687	+203%	+$1.12M	0.02%	784
2023 Q1	$589K	Buy	+4,271	New	+$554K	0.01%	1085
2020 Q3	–	Sell	-38	Closed	-$6K	–	1828
2020 Q2	$6K	Sell	38 -25	-40%	-$3.4K	﹤0.01%	1411
2020 Q1	$6K	Buy	63 +31	+97%	+$3.54K	﹤0.01%	1249
2019 Q4	$4K	Buy	+32	New	+$3.23K	﹤0.01%	1342

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Orion Portfolio Solutions's SRPT Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Sarepta Therapeutics (SRPT) stake by 29% in Q1 2025, buying an estimated $248K and bringing the position to 10,385 shares worth $663K. The position accounts for 0.01% of the portfolio, ranked #1277.

Orion Portfolio Solutions first reported a position in SRPT in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.72M in Q3 2023. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

Orion Portfolio Solutions held 10,385 shares of Sarepta Therapeutics worth $663K as of Q1 2025.
Orion Portfolio Solutions bought 2,358 Sarepta Therapeutics shares in Q1 2025, an estimated $248K.
Sarepta Therapeutics made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1277 holding.
Orion Portfolio Solutions first reported a position in Sarepta Therapeutics in Q4 2019 and has held it in 12 quarters since.
Orion Portfolio Solutions's Sarepta Therapeutics position peaked at $1.72M in Q3 2023.
430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.